Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo.

J Atheroscler Thromb · 2020 · PMC7242225 · PMID 31527323

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

a decreasing trendp = 0.054so close (0.05 < p ≤ 0.1)

Akt phosphorylation at serine 473 showed a decreasing trend in rosuvastatin group as compared with control group ( p = 0.054).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.